Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study
ConclusionThe findings provide evidence that denosumab may suppress the progression of CAC and also regress osseous calcification in severe cases of high bone turnover.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | CT Scan | Dialysis | Electrocardiogram | Heart | Hyperparathyroidism | Orthopaedics | Osteoporosis | PET Scan | Renal Failure | Study | Xgeva